JCT  Vol.6 No.7 , July 2015
Is Use of Radiation Hormesis the Missing Link to a Better Cancer Treatment?
Author(s) Paul A. Oakley*
ABSTRACT
Radiation hormesis is a concept that pervades radiobiological exposures; low doses enhance immune response, while higher doses inhibit immune response. Low-dose Total-Body Irradiation (TBI) therapy offers radiation treatment to cancer patients using the concepts of radiation hormesis and show very good success rates. This phenomenon has been reported elsewhere as the “abscopal effect” and considering the marginal success rates of other treatment agents, like the immunotherapy drug Ipilimumab, TBI therapy may prove to be the missing link to a better cancer treatment.

Cite this paper
Oakley, P. (2015) Is Use of Radiation Hormesis the Missing Link to a Better Cancer Treatment?. Journal of Cancer Therapy, 6, 601-605. doi: 10.4236/jct.2015.67065.
References
[1]   Luckey, T.D. (1980) Hormesis with Ionizing Radiation. CRC Press, Boca Raton.

[2]   Doss, M. (2013) Linear No-Threshold Model vs. Radiation Hormesis. Dose-Response, 11, 495-512.
http://dx.doi.org/10.2203/dose-response.13-005.Doss

[3]   Cuttler, J.M. (2013) Commentary on Fukushima and Beneficial Effects of Low Radiation. Dose-Response, 11, 447-458.
http://dx.doi.org/10.2203/dose-response.13-008.Cuttler

[4]   Feinendegen, L.E., Pollycove, M. and Neumann, R.D. (2013) Hormesis by Low Dose Radiation Effects: Low Dose Cancer Risk Modeling Must Recognize Up-Regulation of Protection. In: Baum, R.P., Ed., Therapeutic Nuclear Medicine, Springer.

[5]   Faguet, G.B. (2005) The War on Cancer: An Anatomy of Failure, a Blueprint for the Future. Springer, Dordrecht.

[6]   Goldstein, I., Madar, S. and Rotter, V. (2012) Cancer Research, a Field on the Verge of a Paradigm Shift? Trends in Molecular Medicine, 18, 299-303.
http://dx.doi.org/10.1016/j.molmed.2012.04.002

[7]   Remington, P.L. and Brownson, R.C. (2011) Fifty Years of Progress in Chronic Disease Epidemiology and Control. MMWR Surveill, 60, 70-77.

[8]   Murphy, J.B. and Morton, J.J. (1915) The Effect of Roentgen Rays on the Rate of Growth of Spontaneous Tumors in Mice. The Journal of Experimental Medicine, 22, 800-803.
http://dx.doi.org/10.1084/jem.22.6.800

[9]   Pollycove, M. and Feinendegen, L.E. (2000) Cellular and Organism Dose-Response: Biopositive (Health Benefit) Effects. Proceedings of International Symposium on Health Benefits of Low-Dose Radiation—The Science and Medical Applications, Washington DC.

[10]   Cuttler, J.M., Pollycove, M. and Welsh, J.S. (2000) Application of Low Doses of Radiation for Curing Cancer. Canadian Nuclear Society Bulletin, 21, 45-50.

[11]   Chaffey, J.T., Rosenthal, D.S., Moloney, W.C. and Hellman, S. (1976) Total Body Irradiation as Treatment for Lymphosarcoma. International Journal of Radiation Oncology * Biology * Physics, 1, 399-405.
http://dx.doi.org/10.1016/0360-3016(76)90004-3

[12]   Choi, N.C., Timothy, A.R., Kaufman, S.D., Carey, R.W. and Aisenberg, A.C. (1979) Low Dose Fractionated Whole Body Irradiation in the Treatment of Advanced Non-Hodgkin’s Lymphoma. Cancer, 43, 1636-1642.
http://dx.doi.org/10.1002/1097-0142(197905)43:5<1636::AID-CNCR2820430512>3.0.CO;2-E

[13]   Sakamoto, K., Myogin, M., Hosoi, Y., Ogawa, Y., Nemoto, K., Takai, Y., Kakuto, Y., Yamada, S. and Watabe, M. (1997) Fundamental and Clinical Studies on Cancer Control with Total or Upper Half Body Irradiation. JASTRO Japanese Society for Therapeutic Radiology and Oncology, 9, 161-175.

[14]   Sakamoto, K. (2004) Radiobiological Basis for Cancer Therapy by Total or Half-Body Irradiation. Nonlinearity in Biology, Toxicology, and Medicine, 2, 293-316.
http://dx.doi.org/10.1080/15401420490900254

[15]   Richaud, P.M., Soubeyran, P., Eghbali, H., Chacon, B., Marit, G., Broustet, A. and Hoerni, B. (1998) Place of Low-Dose Total Body Irradiation in the Treatment of Localized Follicular Non-Hodgkin’s Lymphoma: Results of a Pilot Study. International Journal of Radiation Oncology *Biology* Physics, 40, 387-390.
http://dx.doi.org/10.1016/S0360-3016(97)00722-0

[16]   Wikipedia (2014) Abscopal Effects.

[17]   Postow, M.A., Callahan, M.K., Barker, C.A., Yamada, Y., Yuan, J., Kitano, S., Mu, Z., Rasalan, T., Adamow, M., Ritter, E., Sedrak, C., Jungbluth, A.A., Chua, R., Yang, A.S., Roman, R.A., Rosner, S., Benson, B., Allison, J.P., Lesokhin, A.M., Gnjatic, S. and Wolchok, J.D. (2012) Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma. The New England Journal of Medicine, 366, 925-931.
http://dx.doi.org/10.1056/NEJMoa1112824

[18]   Rattue, G. (2012) Abscopal effect—When Radiation Also Destroys Non Targeted Tumors. Medical News Today, March 12.
http://www.medicalnewstoday.com/articles/242784

[19]   Hodi, F.S., O’Day, S.J., McDermott, D.F., Weber, R.W., Sosman, J.A., Haanen, J.B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J.C., Akerley, W., van den Eertwegh, A.J., Lutzky, J., Lorigan, P., Vaubel, J.M., Linette, G.P., Hogg, D., Ottensmeier, C.H., Lebbé, C., Peschel, C., Quirt, I., Clark, J.I., Wolchok, J.D., Weber, J.S., Tian, J., Yellin, M.J., Nichol, G.M., Hoos, A. and Urba, W.J. (2010) Improved Survival with Ipilimumab in Patients with Metastatic Melanoma. New England Journal of Medicine, 363, 711-723.
http://dx.doi.org/10.1056/NEJMoa1003466

[20]   Robert, C., Thomas, L., Bondarenko, I., O’Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.F., Testori, A., Grob, J.J., Davidson, N., Richards, J., Maio, M., Hauschild, A., Miller Jr., W.H., Gascon, P., Lotem, M., Har-Mankaya, K., Ibrahim, R., Francis, S., Chen, T.T., Humphrey, R., Hoos, A. and Wolchok, J.D. (2011) Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma. New England Journal of Medicine, 364, 2517-2526.
http://dx.doi.org/10.1056/NEJMoa1104621

[21]   Pollycove, M. (2007) Radiobiological Basis of Low-Dose Irradiation in Prevention and Therapy of Cancer. Dose-Response, 5, 26-38.
http://dx.doi.org/10.2203/dose-response.06-112.Pollycove

[22]   Cuttler, J.M. and Pollycove, M. (2003) Can Cancer Be Treated with Low Doses of Radiation? Journal of the American Physicians and Surgeons, 8, 108-111.

[23]   Sakamoto, K. (1999) Reported in Public Meetings Held in Canada, November 8-11.

 
 
Top